These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18719487)

  • 1. Targeted cancer. These "smart weapons" hit cancer in novel ways.
    Held-Warmkessel J
    Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies in colorectal carcinoma: addressing toxicities associated with EGFR inhibitors.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):33-4. PubMed ID: 17824555
    [No Abstract]   [Full Text] [Related]  

  • 3. What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
    Esper P; Gale D; Muehlbauer P
    Clin J Oncol Nurs; 2007 Oct; 11(5):659-66. PubMed ID: 17962174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in cancer therapy: targeted agents.
    Gaguski ME; Begyn P
    Nurs Manage; 2008 May; 39(5):45-8. PubMed ID: 18460908
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapies in breast cancer: challenging questions from oncology nurses.
    Becze E
    ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapies in lung cancer: a tribute to advancements in clinical research.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance imaging of paronychia induced by cetuximab.
    Konheim A; Brebach E; Samuel J; Mellott A; Gandhi M; Lacouture ME
    Clin Exp Dermatol; 2009 Oct; 34(7):e258-9. PubMed ID: 19438534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Great attention should be paid to the adverse drug reactions associated with the use of molecular targeted anticancer drugs].
    Chen ZT; Duan YZ; Xu JC
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):881-4. PubMed ID: 20193323
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
    Wilkes G
    Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254
    [No Abstract]   [Full Text] [Related]  

  • 12. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging therapies in head and neck cancers: EGFR inhibitors.
    Held-Warmkessel J
    ONS News; 2006; 21(8 Suppl):61-2. PubMed ID: 16925156
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe acneiform rash.
    Yamamoto DS; Viale PH; Zhao G
    Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
    [No Abstract]   [Full Text] [Related]  

  • 15. The era of targeted therapies: increasing role for novel oncologic drugs in dermatology.
    Montella L; Palmieri G; Lacouture M
    Arch Dermatol; 2007 Jun; 143(6):788-9. PubMed ID: 17576948
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral chemotherapy medications: the need for a nurse's touch.
    Winkeljohn DL
    Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent indolent NHL: new strategies for treatment.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):57-8. PubMed ID: 17824567
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing hematologic toxicities in the oncology patient.
    Montoya L
    J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common side effects of anti-EGFR therapy: acneform rash.
    Sipples R
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):28-34. PubMed ID: 16616284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-targeted therapy and related skin toxicity.
    Morse L; Calarese P
    Semin Oncol Nurs; 2006 Aug; 22(3):152-62. PubMed ID: 16893744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.